Adjuvant anlotinib plus TACE in hepatocellular carcinoma with postoperative high-risk recurrence: a single-arm, multi-center, phase II study

Authors

Institutions

Publication Details

Journal
Clinical & Translational Oncology
Published
2026-01-03
DOI
https://doi.org/10.1007/s12094-025-04160-0
Primary Topic
Lung Cancer Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adjuvant anlotinib plus TACE in hepatocellular carcinoma with postoperative high-risk recurrence: a single-arm, multi-center, phase II study

Zi Wang, Jian Ma, Xin Zheng, Jie Tao et al.
Clinical & Translational Oncology
Lung Cancer Research Studies
article

Adjuvant anlotinib plus TACE in hepatocellular carcinoma with postoperative high-risk recurrence: a single-arm, multi-center, phase II study

Zi Wang, Jian Ma, Xin Zheng, Jie Tao, Dong Zhang, Xiaojing Song, Zheng Wu, Lei Zhang, Xue Yang, Kedong Xu
article en

Abstract

No abstract available for this paper.
Clinical & Translational Oncology
First Affiliated Hospital of Xi'an Jiaotong University (CN), First Hospital of Lanzhou University (CN), Lanzhou University (CN)
Good health and well-being
Openalex Percentile: Top 98%
Lung Cancer Research Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.